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Lignosus also known as “Tiger Milk Mushroom,” is classified in the family Polyporaceae
and mainly consumed for its medicinal properties in Southeast Asia and China. The
sclerotium is known as the part with medicinal value and often used by the natives
to treat a variety of ailments. Lignosus tigris Chon S. Tan, one of the species of the
Malaysia Tiger Milk mushroom, has recently been successfully cultivated in laboratory.
Earlier studies have demonstrated the L. tigris cultivar E sclerotia exhibited beneficial
biomedicinal properties. This study evaluated the potential toxicity of L. tigris E sclerotia
in a 28-day sub-acute oral administration in Sprague Dawley (SD) rats. L. tigris E sclerotial
powder was administered orally at three different doses of 250, 500, and 1000mg/kg to
the SD rats once daily, consecutively for 28-days. Body weight of the rats was recorded
and general behavior, adverse effects, and mortality were observed daily throughout the
experimental period. At the end of the experiment, blood hematology and biochemistry,
relative organ weights, and histopathological analysis were performed. Results showed
that there were no mortality nor signs of toxicity throughout the 28-day sub-acute
toxicity study. Oral administration of the L. tigris E sclerotial powder at daily dose up
to 1000mg/kg had no significant effects in body weight, relative organ weight, blood
hematological and biochemistry, gross pathology, and histopathology of the organs.
L. tigris E sclerotial powder did not cause any treatment-related adverse effect in the
rats at different treatment dosages up to 1000mg/kg. As the lethal dose for the rats
is above 1000mg/kg, the no-observed-adverse-effect level (NOAEL) dose is more than
1000mg/kg.
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INTRODUCTION
Lignosus spp. belonging to the Polyporaceae family has been long valued for its medicinal and
functional properties. The species of the Lignosus mushroom including L. dimiticus Ryvarden, L.
ekombitii Douanla-Meli, L. goetzii (Henn.) Ryvarden, L. hainanensis B. K. Cui, L. sacer (Afzel. ex
Fr.) Ryvarden and L. rhinocerotis (Cooke) Ryvarden. L. rhinocerotis (commonly known as the Tiger
Milk Mushroom) is utilized by the local communities in Southeast Asia and China as traditional
medicine. The sclerotium is the part with medicinal values which is used as general tonic and
natural remedy for various ailments.
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In Peninsular Malaysia, the mushroom sclerotia was utilized
by Orang Asli (Semai, Temuan, and Jakun) for treating variety
of illnesses including coughs, asthma, food poisoning, breast
swelling, arthritis, edema, liver diseases, and cancer (Lee et al.,
2009; Ismail, 2010). Local Malay and Chinese traditional
practitioners have used it to treat leukemia, cervical cancer,
intestinal ulcer disease, kidney disease, body swelling, fever,
asthma, and consumed as general tonic (Tan, 2009). In Hong
Kong and China, the mushroom sclerotial is a costly traditional
medicine utilized for the treatment of gastric ulcers and liver-
related diseases, such as hepatitis and cancer (Wong and Cheung,
2009). Recent scientific studies have proved that L. rhinocerotis
has a wide spectrum of bioactive properties. An in vitro study
on the antioxidant activity revealed that the mushroom sclerotial
extracts exhibited potent antioxidant activity (Yap et al., 2013).
Lee et al. (2012) demonstrated that the cold water extract of
L. rhinocerotis sclerotium exhibited significant anti-proliferative
activity against human breast (MCF-7), and lung (A549)
adenocarcinoma cells. The polysaccharides of the L. rhinocerotis
sclerotium were reported to have immunomodulatory effect by
activating human innate immune cells (Wong et al., 2011). The
sclerotial extracts of the L. rhinocerotis have also been reported
to have acute anti-inflammatory activity and antimicrobial
properties against bacteria (Mohanarji et al., 2012; Lee et al.,
2014). It also has the ability to enhance neurite outgrowth in
rat adrenal pheochromocytoma (PC-12) cells (Eik et al., 2012).
Owing to its wide ethnomedicinal usages and supportive data
on its medicinal properties, L. rhinocerotis is potentially to be
developed as health supplement. Toxicity assessments including
sub-acute, chronic, fertility, teratogenic, and mutagenic studies
on L. rhinocerotis sclerotial powder all indicated it is safe for
human consumption (Lee et al., 2011, 2013).
Recently, a new species of Lignosus mushroom collected
from the tropical forest in the state of Pahang, Malaysia has
been identified and named Lignosus tigris Chon S. Tan (Tan
et al., 2013). The sclerotia of this mushroom have also been
used as traditional medicine by the local community. It is not
distinguished from L. rhinocerotis due to its similarity in gross
morphologies (Tan et al., 2013). Yap et al. (2014a) revealed that
the wild type L. tigris possess good nutritive value and exhibited
potent antioxidant activity. Recently, L. tigrismushroomhas been
successfully cultivated by Ligno Biotech (Malaysia).
In our earlier study, the sclerotia of the L. tigris cultivar
E has been shown to have high carbohydrate, protein and
dietary fiber content (Kong et al., 2016). The sclerotia also
contain high amount of potassium which is an essential
electrolytes to maintain body function. Substantial amount of
essential amino acids was found in the sclerotial protein. It
also possesses potent superoxide anion scavenging activity. The
mushroom’s sclerotial extracts show high contents of glucan
and terpenoid, compounds which may exhibit anticancer and
immunomodulatory properties (Huang et al., 2012; Kong et al.,
2016). The study suggested that L. tigris E sclerotia is a promising
medicinal mushroom andmay also be a good source of functional
food and nutraceutical. Therefore, the toxicity data of the
mushroom is essential before it being developed as health
supplement. Acute toxicity assessment has indicated that L. tigris
E sclerotial powder did not exhibit acute toxicity at the dose of
2000mg/kg. In this study, we examined the sub-acute toxicity
of the L. tigris cultivar E to investigate the potential toxicity
of repeated exposure of the mushroom sclerotial powder in
Sprague-Dawley rats.
MATERIALS AND METHODS
Cultivation and Preparation of L. tigris E
Sclerotial Powder
Wild type of L. tigris Chon S. Tan specimen was collected from a
tropical forest in Lata Iskandar (4◦17.46′N 101◦34.41′E), Pahang,
Malaysia (Tan et al., 2013). The fungus identity was verified
by PCR amplification coupled with sequence analysis of the
internal transcribed spacer (ITS) region (Yap et al., 2014b). Live
culture of the fungus was prepared inoculating a small portion
(50mg) of clean sclerotial tissue in potato dextrose agar (PDA)
supplemented with 100 µg/L of streptomycin. Pure and healthy
mycelium culture (200mg) was then inoculated in sterilized 100 g
of brown rice with 100ml of distilled water in a polypropylene
container. The inoculated brown rice was incubated in dark at
24◦C for 3 months. The sclerotia grown from the surface of rice
media were then harvested and freeze dried. The freeze dried
sclerotia were ground into powder using 0.2 µmmesh filter. The
nutritional and amino acid compositions of the sclerotial powder
have been analyzed in our previous study. The sclerotium is rich
in carbohydrate, protein, dietary fibers, minerals and contains
considerable amount of essential amino acids and bioactive
components, such as phenolics, terpenoids, and glucan (Kong
et al., 2016).
Experimental Animals
A total of 80 (40 males and 40 females) Sprague-Dawley
(SD) rats aged 7–8 weeks old were obtained from the Animal
Experimental Unit, University of Malaya. The experimental rats
were housed under the conditions with a 12 h of light/dark
cycle and temperature adjusted between 22 and 25◦C with
60 ± 10% of humidity. Rats were given free access to standard
sterile rodent diet (Altromin #1324 Rodent Maintenance Diet,
Denmark) and water. The experimental procedures were
approved by the Institutional Animal Care and Use Committee,
University of Malaya (UM IACUC—Ethics reference no. 2013-
09-17/MOL/R/TNH).
Dose Formulation and Administration
The sub-acute toxicity study was performed according to
the guidelines of Organization for Economic Co-operation
and Development (OECD) for testing of chemicals, TG 407
(adopted—3 October 2008; OECD, 2008). SD rats were assigned
into four groups; a control group and 3 treatment groups (n= 10;
5 males and 5 females). L. tigris E sclerotial powder was dissolved
in distilled water and administered orally on a daily basis for 28-
days at single doses of 250, 500, and 1000mg/kg with the volume
not exceeding 1ml/100 g. Rats in control group received only
distilled water (1ml/100 g).
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Observations, Examinations, and
Measurements
The behavioral changes of the rats were observed at least once
daily for mortality and signs of toxicity. The body weight of
each rat was measured on the first day of treatment and weekly
thereafter.
Blood Hematological and Biochemical
Analyses
Rats were fasted overnight at the end of 28-days and
anesthetized with ketamine (55mg/kg) and xylazine (5mg/kg).
Blood samples were withdrawn through cardiac puncture.
Hematological and biochemical tests were performed based
on the parameters including red blood cell (RBC) count,
hemoglobin concentration, packed cell volume (PCV), mean
corpuscular volume (MCV), mean corpuscular hemoglobin
(MCH), mean corpuscular hemoglobin concentration (MCHC)
along with platelet, white blood cell (WBC), neutrophil,
lymphocyte, monocyte, eosinophil, basophil, atypical lymphocyte
counts, glucose, urea, creatinine, calcium, inorganic phosphate,
uric acid, sodium, potassium, chloride, total cholesterol,
total protein, albumin, globulin, albumin globulin ratio, total
bilirubin, alkaline phosphatase, serum glutamic oxaloacetic
transaminase (SGOT or AST), and serum glutamic pyruvic
transaminase (SGPT or ALT) (Lee et al., 2013).
Histopathological Study
After blood collection, rats were euthanized by anesthetic
overdose of 200 mg/kg sodium pentobarbital. Selected vital
organs (heart, lungs, liver, spleen, and kidneys) and reproductive
organs (uterus, ovaries, prostate, testes, and seminal vesicles)
were excised, weighed, and fixed in 10% buffered formalin
with the exception of the testes which were fixed in modified
Davidson’s fluid. The relative organ weight was calculated as
(organ/body weight) × 100%. After fixation, the tissues were
subjected to hematoxylin and eosin staining. Signs of toxicity
in the selected organs were observed by light microscopic
examinations. Changes in the cardiac muscle fibers, such as
degeneration, inflammation, and necrosis, and lung tissue
including inflammatory exudate in the alveolar or interstitial
spaces and degeneration were inspected. Other toxicity
parameters, such as necrosis of renal tubules or glomerular;
changes in liver architecture, fat content and congestion
in hepatocytes, evidence of cholangitis and occurrence of
inflammatory cell infiltrate in the portal tracts; and alterations
of spleen architecture or signs of infection were observed (Kong
et al., 2016). Histologic structures of the female and male
reproductive organs of the rats were also examined.
Statistical Analysis
Statistical analysis was performed using IBM SPSS (Statistical
Package for Social Sciences) Statistics 22. All data were expressed
as means ± standard error of the mean (SEM). Dunnett t
(two-sided) test was used to determine the statistical differences
between the means of control and treatment groups. Dunnett
T3 test was used on condition of variance heterogeneity. Levene
statistics was used to calculate the homogeneity of variances.
All differences were considered statistically significant at the
p < 0.05 level.
RESULTS
General Findings
The oral administration of L. tigris E sclerotial powder at
different doses did not produced any mortality or abnormal
clinical signs. There were no abnormal changes in body weights
in either sex caused by the oral administration of the L.
tigris E sclerotial powder (Figure 1). Normal body weight
gain was observed in both male and female rats of all the
treated and control groups throughout the experimental period
(Table 1).
Blood Hematological and Biochemical
Parameters
The effects of daily administration of L. tigris E sclerotial powder
for 28 consecutive days on hematological and biochemical
parameters are presented in Tables 2, 3. A few statistically
significant differences between control and treated groups of
the male and female rats were noted with respect to both
hematological (Table 2), and biochemical (Table 3) parameters.
Decreasing MCV, MCH, and neutrophil counts were noted in
low (250mg/kg) and middle (500mg/kg) doses treated male rats.
MCV level in males of the both 250 and 500mg/kg groups
were significantly lower than the control group. MCH level
and neutrophil counts in males of the 250 and 500mg/kg
groups, respectively, were also significantly lower than the
control group. Significant differences for RBC, hemoglobin, PCV,
MCH, MCHC, platelet, WBC, and lymphocyte counts were
observed in the treated female rats. Both 250 and 500mg/kg
treated female groups exhibited significantly higher RBC and
lower MCH and MCHC than the control group. Hemoglobin
level in females of the 250 and 1000mg/kg groups were
significantly higher than the control group. The PCV level
in all the treated female groups was also significantly higher
compared to control group. The 250mg/kg group of the female
rats showed higher platelet and WBC counts than the control
group (p < 0.05). Similarly, the female rats in 1000mg/kg
group showed higher lymphocyte counts (p < 0.05) than the
control group.
Serum biochemistry analysis showed statistically significant
differences in a few parameters in both treated males and
females. Urea level in males of the 250mg/kg group was
significantly lower than the control group. The males of the
500mg/kg group showed lower level (p < 0.05) of calcium and
inorganic phosphate compared to control group. Similarly, total
cholesterol level was also significantly lower in the 250 and
500mg/kg male rats. In the treated female rats, the 250mg/kg
group exhibited higher level (p < 0.05) of calcium, inorganic
phosphate, potassium, and SGOT compared to the control group.
High potassium level was also observed in the females of the
500mg/kg group (p < 0.05). These alterations attained statistical
significance in the mid-dose and lowest-dose groups only and did
not follow a dose-dependent pattern.
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FIGURE 1 | Body weight of control and treated (A) male and (B) female rats with 250, 500, and 1000mg/kg of L. tigris E (LTE) sclerotial powder for
28-days. Body weight is shown as mean ± SD (n = 5).
TABLE 1 | Body weight gain of male and female rats treated with L. tigris E sclerotial powder for 28-days.
Treatment Body weight gain (g)
Male Female
Day 7 Day 14 Day 21 Day 28 Day 7 Day 14 Day 21 Day 28
Control 43.5±4.7 82.4± 3.6 111.7± 7.5 136.1± 8.0 33.3± 7.7 58.6± 13.7 87.9± 20.9 106.9±20.6
1000mg/kg 43.0±2.0 78.6± 4.6 108.7± 11.3 134.0± 13.4 41.4± 3.2 64.9± 10.2 87.1± 13.4 107.2±9.3
500mg/kg 39.1±5.0 79.7± 8.1 99.6± 9.5 117.1± 14.5 25.6± 5.2 46.9± 6.0 65.8± 6.8 88.1±11.3
250mg/kg 34.2±9.6 72.7± 18.4 101.6± 22.0 124.6± 24.6 32.7± 13.1 58.9± 18.0 83.5± 22.4 108.4±23.4
Values are expressed in mean ± SD (n = 5/group). No significance difference in the body weight gain was observed between the control and treated rats (p > 0.05).
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TABLE 2 | Hematological values of male and female rats treated with 250, 500, and 1000mg/kg of L. tigris E sclerotial powder for 28-days.
Parameter Treatment
Control 1000mg/kg 500mg/kg 250mg/kg
MALE
RBC (X 1012/L) 7.50± 0.46 7.56± 0.11 8.00± 0.22 8.54± 0.77
Hemoglobin (G/DL) 15.98± 0.75 15.64± 0.49 15.98± 0.30 16.2± 1.15
PCV (%) 48.00± 2.65 47.60± 0.55 49.40± 0.55 48.80± 2.68
MCV (FL) 64.20± 2.17 62.60± 0.89 61.40± 1.95** 57.20± 1.48**
MCH (PG) 21.20± 0.84 20.60± 0.89 20.00± 0.71 19.00± 0.00**
MCHC (G/DL) 33.20± 1.79 33.00± 1.41 32.40± 0.55 33.20± 0.45
Platelet count (X 109/L) 827.40± 138.51 935.40± 163.05 981.80± 100.36 926.80± 93.71
WBC (X 109/L) 9.38± 2.01 11.14± 2.78 10.48± 1.71 10.48± 1.47
Neutrophil (%) 47.40± 12.16 32.00± 15.52 19.40± 3.65** 26.20± 7.09
Lymphocyte (%) 44.60± 17.34 62.80± 18.7 76.20± 4.32 68.40± 6.73
Monocyte (%) 7.80± 5.72 5.00± 4.12 4.40± 1.52 5.20± 2.17
Eosinophil (%) 0.00± 0.00 0.00± 0.00 0.00± 0.00 0.00± 0.00
Basophil (%) 0.00± 0.00 0.00± 0.00 0.00± 0.00 0.00± 0.00
Atypical lymphocyte (%) 0.20± 0.45 0.20± 0.45 0.00± 0.00 0.20± 0.45
FEMALE
RBC (X 1012/L) 6.44± 0.54 7.12± 0.28 7.80± 0.42** 8.40± 0.48**
Hemoglobin (G/DL) 13.44± 1.11 14.94± 0.45** 14.70± 0.69 16.30± 0.71**
PCV (%) 39.20± 2.39 43.60± 1.14** 46.00± 2.35** 50.00± 1.58**
MCV (FL) 61.40± 1.67 61.20± 1.10 59.20± 1.92 59.80± 1.92
MCH (PG) 21.00± 0.00 21.20± 0.45 19.00± 0.71** 19.60± 0.55**
MCHC (G/DL) 34.20± 1.10 34.20± 0.45 31.80± 0.45** 32.60± 0.55**
Platelet count (X 109/L) 798.40± 83.94 763.80± 114.88 956.80± 212.12 1001.80± 25.68**
WBC (X 109/L) 5.46± 1.96 7.44± 0.68 7.82± 3.26 9.82± 1.70**
Neutrophil (%) 18.40± 7.89 9.80± 2.86 11.00± 3.46 15.20± 8.64
Lymphocyte (%) 75.60± 6.58 85.80± 3.96** 84.00± 3.81 79.60± 7.09
Monocyte (%) 6.00± 2.12 4.40± 1.14 4.60± 2.70 5.20± 4.21
Eosinophil (%) 0.00± 0.00 0.00± 0.00 0.40± 0.89 0.00± 0.00
Basophil (%) 0.00± 0.00 0.00± 0.00 0.00± 0.00 0.00± 0.00
Atypical lymphocyte (%) 0.00± 0.00 0.00± 0.00 0.00± 0.00 0.00± 0.00
Values are expressed in mean ± SD (n = 5/group). ** Significant difference with control (ANOVA, Dunnett’s t (two-sided) test, p < 0.05).
Relative Organ Weights
Relative organ weights of the treated and control rats are shown
in Table 4. The relative organ weight of each organ of both
male and female rats in the treatment groups did not show any
significant differences (p > 0.05) compared to the control.
Histopathology Analysis
Light microscopic examination of the vital organs including
heart, lung, liver, spleen, kidney, ovary, uterus, testis, epididymis,
prostate, and seminal vesicle of the rats in all the treated and
control groups did not reveal any gross pathological lesions. No
significant differences were found in the histological examination
of the organ sections in the tissue of rats treated with 250, 500,
and 1000mg/kg of L. tigris E sclerotial powder as compared to
those of controls. The histological sections of heart, lung, liver,
spleen, kidney, ovary, uterus, testis, epididymis, prostate, and
seminal vesicle of the control and treated rats are illustrated
in Figures 2, 3. In both the control and treated female and
male rats, the heart shows normal cardiac muscle fibers and
lungs show normal alveolar structure with no treatment-related
inflammatory response. No histopathological changes were
observed in the kidneys and liver. Normal glomeruli, tubules
and interstitial space were observed in the kidneys, while normal
architecture, hepatocytes, and portal tract with no congestion
of sinusoids and fatty changes were seen in the liver. Similarly,
normal structure and histology of the spleen were also observed
in all the rats. Although mild congestion was observed in the
lung, liver, and kidney of the treated and control groups of both
sexes, these findings were incidental or spontaneous with no
relation to L. tigris E sclerotial powder treatment. Administration
of L. tigris E sclerotial powder at a daily dose of up to 1000mg/kg
for 28 consecutive days also did not showed any toxic effects on
the reproductive systems of the rats. Histological analysis on the
rat testes showed normal seminiferous tubules, spermatogonia,
spermatocytes, and interstitial tissues; epididymis shows normal
epithelial and basal cells; prostate shows normal glands and
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TABLE 3 | Serum biochemical values of male and female rats treated with 250, 500, and 1000mg/kg of L. tigris E sclerotial powder for 28-days.
Parameter Treatment
Control 1000mg/kg 500mg/kg 250mg/kg
MALE
Glucose (mmol/L) 6.00± 0.77 6.00± 1.08 6.24± 0.68 6.66± 1.63
Urea (mmol/L) 6.44± 0.93 6.58± 0.98 5.38± 1.17 4.94± 0.21**
Creatinine (µmol/L) 15.20± 2.86 15.40± 3.65 12.00± 3.39 16.60± 4.04
Calcium (mmol/L) 2.52± 0.10 2.50± 0.05 2.37± 0.09** 2.49± 0.08
Inorganic phosphate (mmol/L) 3.75± 0.21 3.26± 0.35 3.11± 0.36** 3.17± 0.50
Uric acid (mmol/L) 0.11± 0.07 0.09± 0.02 0.07± 0.05 0.08± 0.06
Sodium (mmol/L) 145.80± 1.48 145.60± 1.14 146.20± 1.92 146.00± 2.00
Potassium (mmol/L) 4.48± 0.36 4.28± 0.38 4.84± 1.04 5.24± 1.00
Chloride (mmol/L) 107.00± 1.87 106.00± 0.71 109.20± 2.59 109.80± 1.48
Total cholesterol (mmol/L) 2.32± 0.47 2.10± 0.33 1.40± 0.16** 1.00± 0.48**
Total protein (G/L) 57.80± 2.59 58.20± 3.70 44.68± 22.08 54.60± 3.05
Albumin (G/L) 36.60± 1.95 37.20± 1.92 34.40± 1.52 34.60± 1.82
Globulin (G/L) 21.20± 0.84 21.00± 2.00 20.00± 1.00 20.00± 1.41
Total bilirubin (µmol/L) 1.80± 0.45 2.00± 0.00 2.00± 0.00 2.00± 0.00
Alkaline phosphatase (IU/L) 196.40± 42.44 169.20± 31.14 215.80± 20.85 177.00± 20.20
SGOT (AST) (IU/L) 239.00± 46.48 254.60± 24.63 252.00± 32.83 244.00± 43.00
SGPT (ALT) (IU/L) 61.20± 7.50 59.20± 5.22 65.60± 8.26 67.40± 8.44
GGT (IU/L) 1.80± 1.30 0.00± 0.00 0.00± 0.00 0.00± 0.00
FEMALE
Glucose (mmol/L) 6.08± 0.37 6.48± 0.99 6.60± 0.51 7.28± 0.70
Urea (mmol/L) 7.48± 1.28 8.66± 1.24 7.08± 0.26 7.86± 0.72
Creatinine (µmol/L) 16.60± 5.13 18.00± 1.87 23.80± 4.15 23.60± 6.35
Calcium (mmol/L) 2.43± 0.05 2.36± 0.06 2.52± 0.07 2.66± 0.11**
Inorganic phosphate (mmol/L) 2.83± 0.28 2.75± 0.27 3.40± 0.39 3.96± 0.50**
Uric acid (mmol/L) 0.06± 0.01 0.06± 0.01 0.07± 0.01 0.07± 0.01
Sodium (mmol/L) 142.40± 0.89 143.60± 1.14 144.80± 1.10 144.00± 2.55
Potassium (mmol/L) 4.04± 0.70 3.84± 0.30 4.90± 0.37** 5.98± 0.59**
Chloride (mmol/L) 104.00± 1.41 106.60± 1.82 105.80± 0.45 105.40± 1.67
Total cholesterol (mmol/L) 2.16± 0.29 2.02± 0.27 1.62± 0.47 1.90± 0.37
Total protein (G/L) 56.00± 2.92 55.00± 1.87 58.60± 2.61 61.40± 4.83
Albumin (G/L) 35.60± 1.82 34.80± 1.48 37.40± 1.34 39.80± 3.70
Globulin (G/L) 20.40± 1.14 20.20± 0.84 21.20± 1.79 21.60± 1.34
Total bilirubin (µmol/L) 1.60± 0.55 2.00± 0.00 1.00± 0.00 1.00± 0.00
Alkaline phosphatase (IU/L) 131.20± 20.17 155.00± 40.74 144.80± 28.49 115.40± 22.78
SGOT (AST) (IU/L) 212.20± 19.20 188.60± 21.95 242.20± 23.88 295.00± 28.06**
SGPT (ALT) (IU/L) 55.80± 6.30 54.20± 8.79 56.40± 3.97 61.00± 2.83
GGT (IU/L) 2.00± 0.71 0.40± 0.55 1.40± 2.61 1.60± 1.14
Values are expressed in mean ± SD (n = 5/group). ** Significant difference with control (ANOVA, Dunnett’s t (two-sided) test, p < 0.05).
interstitial; and seminal vesicle shows normal glands. The
reproductive organs of the female rats (ovary and uterus) showed
normal histological structures.
DISCUSSION
The present study showed the safety profile of L. tigris E
sclerotium in sub-acute oral toxicity study done on SD rats.
The results of this 28-day toxicity study revealed no significant
adverse effects following oral administration of L. tigris E
sclerotial powder at 3 different doses (250, 500, and 1000mg/kg).
Changes in body weight and internal organs have been used
as a reference to indicate the harmful effects from exposure to
potentially toxic substances of drugs and chemicals (Teo et al.,
2002; Hilaly et al., 2004; Mukinda and Eagles, 2010). In this study,
all the rats at the respective dosage groups showed a similar
growth pattern (Figure 1), and continued normal weight gain
(Table 1) throughout the 28-day toxicological study. In addition,
there is no significant differences in the relative organ weights
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TABLE 4 | Relative organ weight of male and female rats treated with L. tigris E sclerotial powder for 28-days.
Organ Treatment
Male Female
Control 1000mg/kg 500mg/kg 250mg/kg Control 1000mg/kg 500mg/kg 250mg/kg
Heart 0.380± 0.027 0.369± 0.032 0.386±0.019 0.356± 0.010 0.332± 0.170 0.371± 0.015 0.410± 0.049 0.372±0.041
Lungs 0.390± 0.019 0.352± 0.030 0.355±0.018 0.383± 0.076 0.440± 0.030 0.433± 0.030 0.594± 0.153 0.472±0.025
Liver 3.062± 0.235 2.818± 0.328 2.750±0.123 2.793± 0.206 3.272± 0.190 3.12± 0.259 2.975± 0.249 3.238±0.180
Spleen 0.208± 0.010 0.196± 0.017 0.189±0.011 0.208± 0.017 0.196± 0.021 0.21± 0.044 0.238± 0.029 0.224±0.027
Right kidney 0.349± 0.032 0.331± 0.040 0.345±0.028 0.356± 0.019 0.363± 0.038 0.341± 0.025 0.350± 0.021 0.388±0.055
Left kidney 0.340± 0.026 0.324± 0.042 0.332±0.017 0.353± 0.009 0.359± 0.033 0.340± 0.017 0.338± 0.026 0.376±0.048
Prostate + seminal
vesicle + glands/ uterus
0.659± 0.045 0.609± 0.038 0.688±0.027 0.710± 0.079 0.231± 0.050 0.239± 0.094 0.221± 0.049 0.162±0.018
Right testis/ovary 0.436± 0.035 0.481± 0.053 0.482±0.040 0.430± 0.037 0.025± 0.003 0.023± 0.003 0.030± 0.004 0.023±0.003
Left testis/ovary 0.434± 0.023 0.476± 0.038 0.471±0.031 0.418± 0.027 0.030± 0.006 0.026± 0.003 0.032± 0.005 0.025±0.004
Right epididymis 0.154± 0.010 0.160± 0.011 0.161±0.009 0.166± 0.009 − − − −
Left epididymis 0.148± 0.011 0.159± 0.010 0.16±0.006 0.162± 0.011 − − − −
Values are expressed in mean ± SD (n = 5/group). There was no significance difference in the relative organ weight between the control and treated rats (p > 0.05).
FIGURE 2 | Representative photos of hematoxylin and eosin stain (100 × magnification) of vital organs (heart, lung, spleen, kidney, and liver) of the
control and treated rats (250, 500, and 1000mg/kg of L. tigris E sclerotial powder). No significant histopathological abnormality was observed in the organs of
the control and treated rats. AS, alveolar space; I, interstitium; WP, white pulp; RP, red pulp; G, glomerulus; T, tubule; PT, portal tract; H, hepatocyte.
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FIGURE 3 | Representative photos of hematoxylin and eosin stain (100 × magnification) of reproductive organs (ovary, uterus, testis, epididymis,
prostate, and seminal vesicle) of the control and treated rats (250, 500, and 1000mg/kg of L. tigris E sclerotial powder). No significant histopathological
abnormality was observed in the organs of the control and treated rats. O, oocyte; F, follicle; ES, endometrial stroma; EG, endometrial gland; ST, seminiferous tubule;
SP, spermatozoids; MS, mature sperm; E, epithelium; L, lumen; BC, basal cells; G, gland.
(Table 4) between the male and female rats in all the treated and
control groups. This indicated that there is no gross toxic effect
due to oral administration of L. tigris E sclerotial powder at a daily
dose up to 1000mg/kg for 28 consecutive days.
The hematopoietic system is a sensitive target for toxic
substances and changes in hematological parameters provide
high predictive value of toxicity or pathological status in human
using the data obtained from animal model study (Olson et al.,
2000; Adeneye et al., 2006). In this study, alterations in the
hematological parameters of the rats treated with the L. tigris
E sclerotial powder did not produce any treatment-associated
hematopoiesis toxicity. Although there are significant decrease
of MCV in 250 and 500mg/kg groups, decrease of MCH
in 250mg/kg group and decrease of neutrophil percentage in
500mg/kg group of the treated male rats, but the differences
were not dose-related or reflected by any changes in other related
parameters. With respect to the observed changes in hematology
parameters in the treated female rats, including the increase of
RBC, decrease ofMCH andMCHC in 250 and 500mg/kg groups;
increase of hemoglobin and PCV in 250 and 1000mg/kg groups;
increase of platelet andWBC in 250mg/kg group, and increase of
lymphocyte in 1000mg/kg group, the differences were assumed
to be toxicologically irrelevant because the values were within
the normal range of laboratory reference data (Petterino and
Argentino-Storino, 2006; Han et al., 2010). Hence, the variations
observed in the hematological parameters were considered to be
unrelated with the administration of L. tigris E sclerotial powder
because the changes were neither the sex nor the dose-related and
the correlative findings in the organ weight and histopathological
analyses were absent.
In addition to the hematological analysis, clinical
biochemistry data of the blood also plays an important role
in determination of the toxicity induced by drugs and chemical
substances. Biochemical parameters for total protein, albumin,
globulin, total bilirubin, alkaline phosphatase, SGOT, SGPT,
and GGT are good indicators of hepatic functions; while urea,
creatinine, and uric acid levels are good indicators of renal
functions. In the present study, significant differences (p < 0.05)
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in the SGOT were observed in females of the 250mg/kg
treatment group. The changes were not dose-related and are
unlikely to be of any clinical significance as the other hepatic
function test parameters did not show any significant differences.
Moreover, there were no lesions or pathological changes were
observed in the liver of the rats, indicating that L. tigris E
sclerotial powder did not cause hepatotoxicity or deterioration
of the liver function.
Elevations in serum urea, creatinine, and electrolytes
(potassium, inorganic phosphate, sodium, and chloride) levels
are relatively sensitive indicators for renal injury. This study
showed that there are no significant changes in the level of
urea and creatinine in all the treated rats with the exception
of the urea level in males of low dose 250 mg/kg treatment
group which is slightly lower (p < 0.05) than the rats of the
control group, which is likely an incidental event. Although,
an increase of serum potassium concentrations (p < 0.05)
was observed in the middle dose (500mg/kg) and low dose
(250mg/kg) of the female rats, the values were within the normal
range (Petterino and Argentino-Storino, 2006; Han et al., 2010).
Differences in inorganic phosphate (p < 0.05) (decrease in
males of the 500mg/kg treatment group and increase in females
of the 250mg/kg treatment group) were neither the sex nor
the dose-related. Other serum electrolyte parameters in all the
treated rats are not significantly different from the control rats.
As the differences of the serum urea, inorganic phosphate and
potassium are unlikely to be of any clinical significance and
no pathological changes was found in the glomeruli, tubules
and interstitial space structures of kidney tissue in treated rats,
therefore the administration of L. tigris E sclerotial powder up to
1000mg/kg for 28 consecutive days has no deleterious effects on
the renal function.
The gross examinations of the vital organs of rats treated with
different dosage forms of L. tigris E sclerotial powder did not
show any differences in color and texture compared with the
organs of the control rats. Besides, no hypertrophy of organs
were observed in this study, indicating no toxic effects of L.
tigris E sclerotial powder on the rats. Microscopic examinations
revealed no changes in the cell structures or pathologies in the
heart, lungs, liver, kidneys, spleen, and the reproductive organs
including uterus, ovaries, testes, prostate, and seminal vesicle
of the treated rats. The histological examinations are in good
supportive correlation with the findings from hematological and
clinical biochemistry studies. It showed that L. tigris E sclerotial
powder did not cause any remarkable alteration or damages on
the blood cells, serum and the vital organs.
The sclerotium of the Tiger Milk mushrooms, Lignosus
spp. have been consumed by the indigenous people and local
communities as traditional medicine in the Southeast Asia and
China for its medicinal properties and or as general tonic. L. tigris
was recently discovered as distinct from its other more well-
known species, the L. rhinocerotis and has subsequently been
successfully cultivated. Our earlier study (Kong et al., 2016)
showed that the mushroom sclerotia are nutritive and contain
numerous bioactive compounds, such as phenolics, terpenoids,
and glucans which are known to contain anti-cancer, anti-
inflammatory, antioxidant, and immunomodulatory activities. In
summary, this 28-day sub-acute toxicity study has successfully
demonstrated the safety profile of the L. tigris E sclerotia. The
results obtained in the study suggest that L. tigris E sclerotial
powder is not toxic at all the tested dosages (250, 500, and
1000mg/kg), and did not produce any signs of toxicity or showed
any evidence of systems disruptions as tested. The NOAEL dose
for sub-acute toxicity of the L. tigris E sclerotial powder is
more than 1000mg/kg. This data indicates that the mushroom
is safe to consume at the dose up to 1000mg/kg. However,
further evaluations on the chronic toxicity, effect on fertility,
teratogenicity and mutagenicity are necessary to further validate
the safety consumption of this mushroom.
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